Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JPMHC 2021
JPMHC 2021
JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'
Fierce Pharma
Mon, 01/11/21 - 07:03 pm
Genentech
JPMHC 2021
partnerships
Why Editas Medicine Stock Is Tumbling Today
Motley Fool
Mon, 01/11/21 - 06:50 pm
Editas Medicine
JPMHC 2021
EDIT-301
EDIT-101
8 things I won't miss about the Westin St. Francis as JPM goes virtual
Fierce Pharma
Mon, 01/11/21 - 06:46 pm
JPMHC 2021
virtual meetings
pandemic
COVID-19
John Maraganore makes a bold promise ahead of #JPM21 — aiming to take Alnylam into the ranks of biotech's best
Endpoints
Mon, 01/11/21 - 10:41 am
Alnylam
Pharma CEOs
John Maraganore
JPMHC 2021
JPM: Bluebird to spin off cancer therapies into new company
Fierce Biotech
Mon, 01/11/21 - 10:26 am
Bluebird Bio
spinoffs
oncology
JPMHC 2021
Oncology Newco
Biopharma CEOs on What to Expect at 2021 J.P. Morgan Healthcare Conference
BioSpace
Mon, 01/11/21 - 12:03 am
JPMHC 2021
Pharma CEOs
Windtree Therapeutics
NeuBase
Cerevance
Medtronic, J&J and Edwards among medtechs to headline at JP Morgan
Medtech Dive
Tue, 01/5/21 - 10:14 am
devices
Medtech
JPMHC 2021
Medtronic
JNJ
Edwards
Pages
« first
‹ previous
1
2